Using what you get: dynamic physiologic signatures of critical illness

Por Holder, Andre L., Clermont, Gilles
Publicado no Crit Care Clin (2015)

Assignment of Neisseria meningitidis serogroup A and C class-specific anticapsular antibody concentrations to the new standard reference serum CDC1992.

Por Holder, P K, Maslanka, S E, Pais, L B, Dykes, J, Plikaytis, B D, Carlone, G M
Publicado em 1995

Reliability and feasibility of a near patient test for C-reactive protein in primary care.

Por Hobbs, F D, Kenkre, J E, Carter, Y H, Thorpe, G H, Holder, R L
Publicado em 1996

New Ceratocystis species associated with rapid death of Metrosideros polymorpha in Hawai’i

Por Barnes, I., Fourie, A., Wingfield, M.J., Harrington, T.C., McNew, D.L., Sugiyama, L.S., Luiz, B.C., Heller, W.P., Keith, L.M.
Publicado no Persoonia (2018)

SP6616 as a new Kv2.1 channel inhibitor efficiently promotes β-cell survival involving both PKC/Erk1/2 and CaM/PI3K/Akt signaling pathways

Por Zhou, T T, Quan, L L, Chen, L P, Du, T, Sun, K X, Zhang, J C, Yu, L, Li, Y, Wan, P, Chen, L L, Jiang, B H, Hu, L H, Chen, J, Shen, X
Publicado no Cell Death Dis (2016)

Irinotecan, cisplatin and mitomycin in inoperable gastro-oesophageal and pancreatic cancers – a new active regimen

Por Slater, S, Shamash, J, Wilson, P, Gallagher, C J, Slevin, M L
Publicado em 2002

Plectosphaerella species associated with root and collar rots of horticultural crops in southern Italy

Por Carlucci, A., Raimondo, M.L., Santos, J., Phillips, A.J.L.
Publicado em 2012

Multicentre phase II trial of capecitabine plus oxaliplatin (XELOX) in patients with advanced hepatocellular carcinoma: FFCD 03-03 trial

Por Boige, V, Raoul, J-L, Pignon, J-P, Bouché, O, Blanc, J-F, Dahan, L, Jouve, J-L, Dupouy, N, Ducreux, M
Publicado em 2007

Inhibition of colony stimulating factor-1 receptor abrogates microenvironment-mediated therapeutic resistance in gliomas

Por Yan, D, Kowal, J, Akkari, L, Schuhmacher, A J, Huse, J T, West, B L, Joyce, J A
Publicado no Oncogene (2017)

Genomic modelling of the ESR1 Y537S mutation for evaluating function and new therapeutic approaches for metastatic breast cancer

Por Harrod, A, Fulton, J, Nguyen, V T M, Periyasamy, M, Ramos-Garcia, L, Lai, C-F, Metodieva, G, de Giorgio, A, Williams, R L, Santos, D B, Gomez, P J, Lin, M-L, Metodiev, M V, Stebbing, J, Castellano, L, Magnani, L, Coombes, R C, Buluwela, L, Ali, S
Publicado no Oncogene (2017)

Diversity of Amyloid-beta Proteoforms in the Alzheimer’s Disease Brain

Por Wildburger, Norelle C., Esparza, Thomas J., LeDuc, Richard D., Fellers, Ryan T., Thomas, Paul M., Cairns, Nigel J., Kelleher, Neil L., Bateman, Randall J., Brody, David L.
Publicado no Sci Rep (2017)

Critical comparison of methods for fault diagnosis in metabolomics data

Por Koeman, M., Engel, J., Jansen, J., Buydens, L.
Publicado no Sci Rep (2019)

Evaluation and Development of the Macrophage Electrophoretic Mobility (MEM Test for Malignant Disease)

Por Pritchard, J. A. V., Moore, J. L., Sutherland, W. H., Joslin, C. A. F.
Publicado em 1973

Circulating CCL20 as a New Biomarker of Abdominal Aortic Aneurysm

Por Soto, B., Gallastegi-Mozos, T., Rodríguez, C., Martínez-González, J., Escudero, J.-R., Vila, L., Camacho, M.
Publicado no Sci Rep (2017)

DYRK1A promotes dopaminergic neuron survival in the developing brain and in a mouse model of Parkinson's disease

Por Barallobre, M J, Perier, C, Bové, J, Laguna, A, Delabar, J M, Vila, M, Arbonés, M L
Publicado no Cell Death Dis (2014)

From gut dysbiosis to altered brain function and mental illness: mechanisms and pathways

Por Rogers, G B, Keating, D J, Young, R L, Wong, M-L, Licinio, J, Wesselingh, S
Publicado no Mol Psychiatry (2016)

Dementia of the eye: the role of amyloid beta in retinal degeneration

Por Ratnayaka, J A, Serpell, L C, Lotery, A J
Publicado no Eye (Lond) (2015)

Soluble Amyloid-beta Aggregates from Human Alzheimer’s Disease Brains

Por Esparza, Thomas J., Wildburger, Norelle C., Jiang, Hao, Gangolli, Mihika, Cairns, Nigel J., Bateman, Randall J., Brody, David L.
Publicado no Sci Rep (2016)

Whole-body diffusion-weighted MRI: a new gold standard for assessing disease burden in patients with multiple myeloma?

Por Pawlyn, C, Fowkes, L, Otero, S, Jones, J R, Boyd, K D, Davies, F E, Morgan, G J, Collins, D J, Sharma, B, Riddell, A, Kaiser, M F, Messiou, C
Publicado no Leukemia (2016)

Type I collagen degradation product (ICTP) gives information about the nature of bone metastases and has prognostic value in prostate cancer.

Por Kylmälä, T., Tammela, T. L., Risteli, L., Risteli, J., Kontturi, M., Elomaa, I.
Publicado em 1995